(Q72727031)
Statements
Efficacy of etoposide and mitoxantrone in patients with acute myelogenous leukemia refractory to standard induction therapy and intermediate-dose cytarabine with amsidine. Dutch Hematology-Oncology Working Group for Adults (HOVON) (English)
Daenen S
Löwenberg B
Sonneveld P
van Putten WL
Verhoef G
Verdonck LF
van Veldhoven M
1 January 1994